Search research articles
Contact Us
Filters
Showing results (31-40 of 164) with videos related to
Page
of 17
Sort By:
Neuropsychiatric Disease and Treatment
|
May 5, 2009
The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder
Emanuela Mundo, Elisabetta Cattaneo, Silvia Zanoni, et al.
International Journal of Psychiatry in Clinical Practice
|
November 5, 2016
Clinical features associated with increased severity of illness in tertiary clinic referred patients with obsessive compulsive disorder
Bernardo Dell'Osso, Beatrice Benatti, Eric Hollander, et al.
Expert Opinion on Pharmacotherapy
|
May 6, 2016
May selective serotonin reuptake inhibitors (SSRIs) provide some benefit for the treatment of schizophrenia?
Massimiliano Buoli, Marta Serati, Valentina Ciappolino, et al.
Expert Opinion on Pharmacotherapy
|
July 22, 2017
Agomelatine for the treatment of generalized anxiety disorder
Massimiliano Buoli, Silvia Grassi, Marta Serati, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 23, 2008
Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series
Bernardo Dell'osso, Emanuela Mundo, Donatella Marazziti, et al.
Biological Psychiatry
|
May 11, 2015
Psychiatric symptoms in frontotemporal dementia: epidemiology, phenotypes, and differential diagnosis
Daniela Galimberti, Bernardo Dell'Osso, A Carlo Altamura, et al.
Neuropsychiatric Disease and Treatment
|
June 24, 2008
Duration of untreated illness in panic disorder: a poor outcome risk factor?
A Carlo Altamura, Annalisa Santini, Daniele Salvadori, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
September 17, 2005
Some biological correlates of drug resistance in schizophrenia: a multidimensional approach
A Carlo Altamura, Roberta Bassetti, Elisabetta Cattaneo, et al.
F1000Research
|
October 30, 2014
A case of severe psychosis induced by novel recreational drugs
Filippo Dragogna, Lucio Oldani, Massimiliano Buoli, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
October 2, 2012
Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology
A Carlo Altamura, Sara Pozzoli, Alessio Fiorentini, et al.
Page
of 17
Search research articles
Search
Showing results (31-40 of 164) with videos related to
Sort By:
Page
of 17
Neuropsychiatric Disease and Treatment
|
May 5, 2009
The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder
Emanuela Mundo, Elisabetta Cattaneo, Silvia Zanoni, et al.
International Journal of Psychiatry in Clinical Practice
|
November 5, 2016
Clinical features associated with increased severity of illness in tertiary clinic referred patients with obsessive compulsive disorder
Bernardo Dell'Osso, Beatrice Benatti, Eric Hollander, et al.
Expert Opinion on Pharmacotherapy
|
May 6, 2016
May selective serotonin reuptake inhibitors (SSRIs) provide some benefit for the treatment of schizophrenia?
Massimiliano Buoli, Marta Serati, Valentina Ciappolino, et al.
Expert Opinion on Pharmacotherapy
|
July 22, 2017
Agomelatine for the treatment of generalized anxiety disorder
Massimiliano Buoli, Silvia Grassi, Marta Serati, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 23, 2008
Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series
Bernardo Dell'osso, Emanuela Mundo, Donatella Marazziti, et al.
Biological Psychiatry
|
May 11, 2015
Psychiatric symptoms in frontotemporal dementia: epidemiology, phenotypes, and differential diagnosis
Daniela Galimberti, Bernardo Dell'Osso, A Carlo Altamura, et al.
Neuropsychiatric Disease and Treatment
|
June 24, 2008
Duration of untreated illness in panic disorder: a poor outcome risk factor?
A Carlo Altamura, Annalisa Santini, Daniele Salvadori, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
September 17, 2005
Some biological correlates of drug resistance in schizophrenia: a multidimensional approach
A Carlo Altamura, Roberta Bassetti, Elisabetta Cattaneo, et al.
F1000Research
|
October 30, 2014
A case of severe psychosis induced by novel recreational drugs
Filippo Dragogna, Lucio Oldani, Massimiliano Buoli, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
October 2, 2012
Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology
A Carlo Altamura, Sara Pozzoli, Alessio Fiorentini, et al.
Page
of 17